nanoarrays

Hopkins researchers are validating a nanosensor platform to detect SARS-CoV-2 and other viruses that consists of a single-use chip and handheld spectrometer.

Researchers demonstrated that detection of single and clustered circulating trophoblasts could reliably differentiate placenta accreta from normal controls and other disorders, even early in gestation.

The Harvard University spinout uses a combination of proprietary probes, nanoarrays, and convection PCR to target a broad set of molecular biomarkers.